Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Spero Therapeutics (SPRO) Debt Ratio (2016 - 2025)

Spero Therapeutics' Debt Ratio history spans 10 years, with the latest figure at 0.0 for Q4 2025.

  • For Q4 2025, Debt Ratio changed N/A year-over-year to 0.0; the TTM value through Dec 2025 reached 0.0, changed N/A, while the annual FY2025 figure was 0.0, N/A changed from the prior year.
  • Debt Ratio reached 0.0 in Q4 2025 per SPRO's latest filing, up from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.01 in Q1 2022 to a low of 0.0 in Q3 2024.
  • Average Debt Ratio over 5 years is 0.0, with a median of 0.0 recorded in 2021.
  • Peak YoY movement for Debt Ratio: surged 557.5% in 2022, then plummeted 90.19% in 2023.
  • A 5-year view of Debt Ratio shows it stood at 0.0 in 2021, then dropped by 4.64% to 0.0 in 2022, then crashed by 37.99% to 0.0 in 2023, then tumbled by 79.84% to 0.0 in 2024, then surged by 1272.81% to 0.0 in 2025.
  • Per Business Quant, the three most recent readings for SPRO's Debt Ratio are 0.0 (Q4 2025), 0.0 (Q3 2024), and 0.0 (Q2 2024).